Original antigenic sin response to RNA viruses and antiviral immunity

Immune Network

Volumn 16, Issue 5, 2016, Pages 261-270

  Park, Mee Sook ^a   Kim, Jin Il ^a   Park, Sehee ^a   Lee, Ilseob ^a   Park, Man Seong ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Dengue; Influenza; Original antigenic sin; Vaccine

Indexed keywords

ANTIVIRUS AGENT; VACCINE;

ANTIGEN FUNCTION; ANTIGENIC SIN RESPONSE; ANTIGENICITY; DENGUE; DENGUE VIRUS; DRUG EFFICACY; HUMAN; IMMUNITY; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA VIRUS;

EID: 85017569647     PISSN: 15982629     EISSN: 20926685     Source Type: Journal    
DOI: 10.4110/in.2016.16.5.261     Document Type: Review

References (62)

1. Davenport, F. M., A. V. Hennessy, and T. Francis, Jr. 1953. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J. Exp. Med. 98: 641-656.
2. Taylor, A., S. S. Foo, R. Bruzzone, L. V. Dinh, N. J. King, and S. Mahalingam. 2015. Fc receptors in antibody-dependent enhancement of viral infections. Immunol. Rev. 268: 340-364.
3. McHeyzer-Williams, M., S. Okitsu, N. Wang, and L. Heyzer-Williams. 2012. Molecular programming of B cell memory. Nat. Rev.Immunol. 12: 24-34.
4. Netea, M. G., L. A. Joosten, E. Latz, K. H. Mills, G. Natoli, H. G. Stunnenberg, L. A. O'Neill, and R. J. Xavier. 2016. Trained immunity: A program of innate immune memory in health and disease. Science 352: aaf1098.
5. Okhrimenko, A., J. R. Grun, K. Westendorf, Z. Fang, S. Reinke, R. P. von, G. Wassilew, A. A. Kuhl, R. Kudernatsch, S. Demski, C. Scheibenbogen, K. Tokoyoda, M. A. McGrath, M. J. Raftery, G. Schonrich, A. Serra, H. D. Chang, A. Radbruch, and J. Dong. 2014. Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory. Proc. Natl. Acad. Sci. U. S. A. 111: 9229-9234.
6. Rothman, A. L. 2011. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 11: 532-543.
7. Beverley, P. C. 2002. Immunology of vaccination. Br. Med. Bull. 62: 15-28.
8. Tangye, S. G., D. T. Avery, E. K. Deenick, and P. D. Hodgkin. 2003. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J. Immunol. 170: 686-694.
9. Michie, C. A., A. McLean, C. Alcock, and P. C. Beverley. 1992. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360: 264-265.
10. Swain, S. L. 2000. CD4 T-cell memory can persist in the absence of class II. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355: 407-411.
11. Hale, J. S., and R. Ahmed. 2015. Memory T follicular helper CD4 T cells. Front. Immunol. 6: 16.
12. Schmidlin, H., S. A. Diehl, and B. Blom. 2009. New insights into the regulation of human B-cell differentiation. Trends Immunol. 30: 277-285.
13. Benson, M. J., L. D. Erickson, M. W. Gleeson, and R. J. Noelle. 2007. Affinity of antigen encounter and other early B-cell signals determine B-cell fate. Curr. Opin. Immunol. 19: 275-280.
14. Lees, J. R., and D. L. Farber. 2010. Generation, persistence and plasticity of CD4 T-cell memories. Immunology 130: 463-470.
15. Ma, C. S., E. K. Deenick, M. Batten, and S. G. Tangye. 2012. The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 209: 1241-1253.
16. Eisen, H. N. 2014. Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses. Cancer Immunol. Res. 2: 381-392.
17. Farrington, L. A., T. A. Smith, F. Grey, A. B. Hill, and C. M. Snyder. 2013. Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection. J. Immunol. 190: 3410-3416.
18. Johansson, B. E., and E. D. Kilbourne. 1996. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Virology 225: 136-144.
19. Pham, G. H., B. V. Iglesias, and E. J. Gosselin. 2014. Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells. Vaccine 32: 5212-5220.
20. Krammer, F., P. Palese, and J. Steel. 2015. Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr. Top. Microbiol. Immunol. 386: 301-321.
21. Nachbagauer, R., T. J. Wohlbold, A. Hirsh, R. Hai, H. Sjursen, P. Palese, R. J. Cox, and F. Krammer. 2014. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. J. Virol. 88: 13260-13268.
22. Adar, Y., Y. Singer, R. Levi, E. Tzehoval, S. Perk, C. Banet-Noach, S. Nagar, R. Arnon, and T. Ben-Yedidia. 2009. A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine 27: 2099-2107.
23. Hemann, E. A., S. M. Kang, and K. L. Legge. 2013. Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination. J. Immunol. 191: 2486-2494.
24. Zeng, W., A. C. Tan, K. Horrocks, and D. C. Jackson. 2015. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate. Vaccine 33: 3526-3532.
25. Gibbons, R. V. 2010. Dengue conundrums. Int. J. Antimicrob. Agents 36 Suppl 1: S36-S39.
26. Weiskopf, D., and A. Sette. 2014. T-cell immunity to infection with dengue virus in humans. Front. Immunol. 5: 93.
27. McKittrick, N., I. Frank, J. M. Jacobson, C. J. White, D. Kim, R. Kappes, C. DiGiorgio, T. Kenney, J. Boyer, and P. Tebas. 2013. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. Ann. Intern. Med. 158: 19-26.
28. Berger, C. T., V. Greiff, M. Mehling, S. Fritz, M. A. Meier, G. Hoenger, A. Conen, M. Recher, M. Battegay, S. T. Reddy, and C. Hess. 2015. Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection. Hum. Vaccin. Immunother. 11: 391-396.
29. Sallusto, F., A. Lanzavecchia, K. Araki, and R. Ahmed. 2010. From vaccines to memory and back. Immunity 33: 451-463.
30. Tricco, A. C., A. Chit, C. Soobiah, D. Hallett, G. Meier, M. H. Chen, M. Tashkandi, C. T. Bauch, and M. Loeb. 2013. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 11: 153.
31. Johns, M. C., A. A. Eick, D. L. Blazes, S. E. Lee, C. L. Perdue, R. Lipnick, K. G. Vest, K. L. Russell, R. F. DeFraites, and J. L. Sanchez. 2010. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 5: e10722.
32. Eick-Cost, A. A., K. J. Tastad, A. C. Guerrero, M. C. Johns, S. E. Lee, V. H. Macintosh, R. L. Burke, D. L. Blazes, K. L. Russell, and J. L. Sanchez. 2012. Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach. PLoS One 7: e41435.
33. Bergtold, A., D. D. Desai, A. Gavhane, and R. Clynes. 2005. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23: 503-514.
34. Batista, F. D., and M. S. Neuberger. 2000. B cells extract and present immobilized antigen: implications for affinity discrimination. EMBO J. 19: 513-520.
35. Faix, D. J., A. W. Hawksworth, C. A. Myers, C. J. Hansen, R. G. Ortiguerra, R. Halpin, D. Wentworth, L. A. Pacha, E. G. Schwartz, S. M. Garcia, A. A. Eick-Cost, C. D. Clagett, S. Khurana, H. Golding, and P. J. Blair. 2012. Decreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses. PLoS One 7: e34581.
36. Skowronski, D. M., N. Z. Janjua, S. G. De, S. Sabaiduc, A. Eshaghi, J. A. Dickinson, K. Fonseca, A. L. Winter, J. B. Gubbay, M. Krajden, M. Petric, H. Charest, N. Bastien, T. L. Kwindt, S. M. Mahmud, C. P. Van, and Y. Li. 2014. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 9: e92153.
37. Chambers, B. S., K. Parkhouse, T. M. Ross, K. Alby, and S. E. Hensley. 2015. Identification of hemagglutinin residues responsible for H3N2 antigenic drift during the 2014-2015 influenza season. Cell Rep. 12: 1-6.
38. Hancock, K., V. Veguilla, X. Lu, W. Zhong, E. N. Butler, H. Sun, F. Liu, L. Dong, J. R. DeVos, P. M. Gargiullo, T. L. Brammer, N. J. Cox, T. M. Tumpey, and J. M. Katz. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361: 1945-1952.
39. Dormitzer, P. R., G. Galli, F. Castellino, H. Golding, S. Khurana, G. G. Del, and R. Rappuoli. 2011. Influenza vaccine immunology. Immunol. Rev. 239: 167-177.
40. Neumann, G., and Y. Kawaoka. 2011. The first influenza pandemic of the new millennium. Influenza Other Respir. Viruses 5: 157-166.
41. Tan, G. S., P. E. Leon, R. A. Albrecht, I. Margine, A. Hirsh, J. Bahl, and F. Krammer. 2016. Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection. PLoS Pathog. 12: e1005578.
42. Viboud, C., J. Eisenstein, A. H. Reid, T. A. Janczewski, D. M. Morens, and J. K. Taubenberger. 2013. Age- and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky. J. Infect. Dis. 207: 721-729.
43. Reed, C., S. S. Chaves, A. Perez, T. D'Mello, K. P. Daily, D. Aragon, J. I. Meek, M. M. Farley, P. Ryan, R. Lynfield, C. A. Morin, E. B. Hancock, N. M. Bennett, S. M. Zansky, A. Thomas, M. L. Lindegren, W. Schaffner, and L. Finelli. 2014. Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic. Clin. Infect. Dis. 59: 166-174.
44. Morens, D. M., J. K. Taubenberger, G. K. Folkers, and A. S. Fauci. 2010. Pandemic influenza's 500th anniversary. Clin. Infect. Dis. 51: 1442-1444.
45. Tumpey, T. M., C. F. Basler, P. V. Aguilar, H. Zeng, A. Solorzano, D. E. Swayne, N. J. Cox, J. M. Katz, J. K. Taubenberger, P. Palese, and A. Garcia-Sastre. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310: 77-80.
46. Epstein, S. L., C. Y. Lo, J. A. Misplon, and J. R. Bennink. 1998. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160: 322-327.
47. Zaiss, D. M., C. J. Boog, E. W. van, and A. J. Sijts. 2010. Considerations in the design of vaccines that induce CD8 T cell mediated immunity. Vaccine 28: 7716-7722.
48. Murali-Krishna, K., L. L. Lau, S. Sambhara, F. Lemonnier, J. Altman, and R. Ahmed. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286: 1377-1381.
49. Shane, H. L., and K. D. Klonowski. 2014. Every breath you take: the impact of environment on resident memory CD8 T cells in the lung. Front. Immunol. 5: 320.
50. Liang, S., K. Mozdzanowska, G. Palladino, and W. Gerhard. 1994. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152: 1653-1661.
51. Wu, T., Y. Hu, Y. T. Lee, K. R. Bouchard, A. Benechet, K. Khanna, and L. S. Cauley. 2014. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J. Leukoc. Biol. 95: 215-224.
52. Kash, J. C., T. M. Tumpey, S. C. Proll, V. Carter, O. Perwitasari, M. J. Thomas, C. F. Basler, P. Palese, J. K. Taubenberger, A. Garcia-Sastre, D. E. Swayne, and M. G. Katze. 2006. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
53. Taubenberger, J. K., and D. M. Morens. 2008. The pathology of influenza virus infections. Annu. Rev. Pathol. 3: 499-522.
54. Schmid, M. A., M. S. Diamond, and E. Harris. 2014. Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity. Front. Immunol. 5: 647.
55. Avirutnan, P., P. Malasit, B. Seliger, S. Bhakdi, and M. Husmann. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 161: 6338-6346.
56. Dalrymple, N., and E. R. Mackow. 2011. Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J. Virol. 85: 9478-9485.
57. Ghebrehiwet, B., and E. I. Peerschke. 2004. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol. Immunol. 41: 173-183.
58. Dalrymple, N. A., and E. R. Mackow. 2014. Virus interactions with endothelial cell receptors: implications for viral pathogenesis. Curr. Opin. Virol. 7: 134-140.
59. Thomas, K. A., N. M. Valenzuela, and E. F. Reed. 2015. The perfect storm: HLA antibodies, complement, FcgammaRs, and endothelium in transplant rejection. Trends Mol. Med. 21: 319-329.
60. Beltramello, M., K. L. Williams, C. P. Simmons, A. Macagno, L. Simonelli, N. T. Quyen, S. Sukupolvi-Petty, E. Navarro-Sanchez, P. R. Young, A. M. de Silva, F. A. Rey, L. Varani, S. S. Whitehead, M. S. Diamond, E. Harris, A. Lanzavecchia, and F. Sallusto. 2010. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8: 271-283.
61. Short, K. R., E. J. Veldhuis Kroeze, L. A. Reperant, M. Richard, and T. Kuiken. 2014. Influenza virus and endothelial cells: a species specific relationship. Front. Microbiol. 5: 653.
62. Monsalvo, A. C., J. P. Batalle, M. F. Lopez, J. C. Krause, J. Klemenc, J. Z. Hernandez, B. Maskin, J. Bugna, C. Rubinstein, L. Aguilar, L. Dalurzo, R. Libster, V. Savy, E. Baumeister, L. Aguilar, G. Cabral, J. Font, L. Solari, K. P. Weller, J. Johnson, M. Echavarria, K. M. Edwards, J. D. Chappell, J. E. Crowe, Jr., J. V. Williams, G. A. Melendi, and F. P. Polack. 2011. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17: 195-199.